(Reuters) — Private equity firms Carlyle Group LP (CG.O) and TPG Capital Management [TPG.UL] are selling their entire remaining stake in Australian healthcare operator Healthscope Ltd (HSO.AX) in a deal worth about $612 million, IFR reported on Monday, citing a source close to the deal.
Carlyle and TPG are offering 308.2 million shares at a fixed price of A$2.77 each, putting the total deal at about A$853.7 million ($612 million), added IFR, a Thomson Reuters publication. The stake accounts for 17.8 percent of Healthscope’s shares.
TPG and Carlyle declined to comment on the stake sale.
Goldman Sachs is advising on the deal, IFR added.